Human Metabolic Dynamics at Rest and During Aerobic Exercise Under Normobaric Normoxic and Moderate Hypoxic Conditions

Sponsor
Benjamin Gollasch (Other)
Overall Status
Completed
CT.gov ID
NCT03121885
Collaborator
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin (Other)
25
1
22
1.1

Study Details

Study Description

Brief Summary

The aim is to define in detail metabolic pathways at rest and during aerobic exercise in normal and healthy men and women under normobaric normoxic and moderate hypoxic conditions, using metabolomics technologies based on minimally invasive sampling relying on gas chromatography and mass spectrometry.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: 30-minute movement activity
  • Other: Hypoxia
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
MetaboDyn- Liquid-liquid Extraction of Single Drops of Whole Capillary Blood as a Reliable Method of Measuring Metabolic Effects of Exercise: A Pilot Study.
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Jul 20, 2017
Actual Study Completion Date :
Nov 1, 2018

Outcome Measures

Primary Outcome Measures

  1. Coefficient of variation of relative quantities of metabolites and physiological parameters related to its dynamic during exercise under normoxic and hypoxic conditions, using GC-MS. [6 months]

    A drop of capillary blood (20 µl) will be collected from the hyperemic earlobe for metabolomic analysis at the times t = 0 min (before starting), 10 min, 20 min and 30 min during the activity, and t = 50 and 60 min taken in the recovery phase. The oxygen saturation and heart rate will be determined at the same time points by pulse oximetry and heart rate monitoring, as well as blood gas analyses and subjective self-perception of energy availability on a quantitative scale throughout exercise.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  • approval and written, informed consent

  • healthy adults of varying fitness levels (age >18 years to 75 years)

Exclusion criteria:
  • chronic illness requiring any medication

  • pregnancy

  • limitations regarding functioning in the hypoxic chamber

  • inability to follow simple instructions

  • relevant or severe abnormalities in medical history, physical examination, ECG routine laboratory parameters from blood and urine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charité University Experimental & Clinical Research Center Berlin Germany 13125

Sponsors and Collaborators

  • Benjamin Gollasch
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Benjamin Gollasch, Dr. med. Benjamin Gollasch, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT03121885
Other Study ID Numbers:
  • MetaboDyn
First Posted:
Apr 20, 2017
Last Update Posted:
Jan 30, 2019
Last Verified:
Jul 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 30, 2019